发明授权
- 专利标题: Oxazole ketones as modulators of fatty acid amide hydrolase
- 专利标题(中): 恶唑酮作为脂肪酸酰胺水解酶的调节剂
-
申请号: US11708788申请日: 2007-02-20
-
公开(公告)号: US07915270B2公开(公告)日: 2011-03-29
- 发明人: Dale L. Boger
- 申请人: Dale L. Boger
- 申请人地址: US CA La Jolla
- 专利权人: The Scripps Research Institute
- 当前专利权人: The Scripps Research Institute
- 当前专利权人地址: US CA La Jolla
- 代理机构: Schwegman, Lundberg & Woessner P.A.
- 主分类号: C07D403/12
- IPC分类号: C07D403/12 ; A61K31/506
摘要:
Certain oxazole ketone compounds are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders (such as MS).
公开/授权文献
信息查询